Melinda L. Au

Family Medicine

801 E Williams Ave
Fallon, NV 89406

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies.

ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies.

Journal: Journal for immunotherapy of cancer

Published: June 09, 2025

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models.

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models.

Journal: Oncotarget

Published: June 26, 2018

Showing 1-2 of 2

Last Updated: 09/26/2026